May 14, 2024

Opioid Alternative: Rutgers Research Reveals Cannabidiol (CBD) Effectively Treats Dental Pain

” The rise in opioid-related addiction and death has everybody looking for much better options, things that can alleviate serious pain without hurting so numerous patients. We studied cannabidiol or CBD due to the fact that previous research study from other specializeds recommended that it may eliminate dental pain without any psychoactive effects, which is really what everyone wants to discover.”
Can CBD be utilized to manage postoperative pain for patients who have undergone tooth extraction or root canal? “That said, the outcomes of this study are strong enough to make a compelling case to utilize pure CBD like Epidiolex for oral discomfort. A larger stage 3 trial will be the next step to get FDA approval for Epidiolex or other pure CBD options to utilize for oral pain management.

A Rutgers study has discovered that CBD, a non-addictive marijuana derivative, substantially lowers dental pain, presenting a more secure option to opioids. The research study, which included monitoring pain reduction in participants, suggests CBDs potential in dental pain management, with further research study and a stage III trial planned.
Rutgers researchers report that CBD effectively minimizes dental pain, using a prospective alternative to opioids. Further research is prepared to confirm these findings and explore CBDs applications in pain management.
In a groundbreaking research study that could reinvent oral pain management, Rutgers researchers have actually found that cannabidiol (CBD)– the non-addictive cannabis derivative– alleviates acute oral pain.
CBD as a Safer Pain Management Option
This first-of-its-kind result appears in the Journal of Dental Research and indicates that CBD, which produces no “high” among users, may be a similarly efficient however far safer option to addictive opioid pain relievers.

” The very first line of defense for dental pain has actually constantly been anti-inflammatory medications like acetaminophen (Tylenol), ibuprofen (Advil, Motrin) or naproxen (Aleve), but many patients cant take such medications or cant get enough relief from them, so dental practitioners have actually traditionally been among the largest prescribers of opioid medications, either alone or in mix with these other medications,” stated lead study author Vanessa Chrepa, an associate professor at the Rutgers School of Dental Medicine and director of translational and clinical research at the schools department of endodontics.
” The rise in opioid-related dependency and death has everybody trying to find much better alternatives, things that can ease serious pain without injuring numerous clients. Much of that research study has focused on another component of marijuana called THC, however THC is psychoactive. It gets users high and has other unfavorable impacts. We studied cannabidiol or CBD because previous research from other specializeds recommended that it might relieve oral pain without any psychoactive results, which is truly what everyone wants to find.”
Medical Trial and Promising Findings
The scientific trial included 61 participants with serious tooth discomfort who were arbitrarily assigned to receive either one of two dosages of an FDA-approved pure CBD option called Epidiolex or a placebo. Scientist kept an eye on client pain levels for three hours with a visual analog scale (VAS), a standard tool for evaluating pain strength.
Both CBD groups reported considerably more discomfort reduction than did the placebo group. About 85 percent of CBD users reported a minimum of a 50 percent decrease in their initial discomfort, and both CBD groups reached a mean 70 percent decrease in pain.
Another essential finding of the research study was the boost in bite force amongst participants who got CBD, which suggests the substance improved tooth function and hence might show particularly advantageous for those with oral pain that affects their capability to chew.
Side results like sedation, diarrhea, and abdominal discomfort occurred more often in the CBD groups than the placebo group. There were, additionally, constraints to the study, including the little sample size, and recommend that more substantial research is essential to verify these findings and explore the wider applications of CBD in pain management.
Future Research and Phase III Trial
Prepare for a larger-scale phase III medical trial are underway, intending to construct on these appealing outcomes and fully clarify CBDs safety profile for dealing with oral discomfort.
” There are more things to study with follow-up research study. Can CBD be used to manage postoperative discomfort for patients who have undergone tooth extraction or root canal? Can we get back at better discomfort relief by combining it with other agents like Tylenol?” Chrepa said. “That stated, the outcomes of this research study are strong enough to make a compelling case to use pure CBD like Epidiolex for oral pain. A larger stage 3 trial will be the next step to get FDA approval for Epidiolex or other pure CBD solutions to use for dental pain management. I am eagerly anticipating equating this into typical practice. It will tremendously assist clients with severe tooth pain and perhaps other acute inflammatory discomfort conditions.”
Referral: “Cannabidiol as an Alternative Analgesic for Acute Dental Pain” by V. Chrepa, S. Villasenor, A. Mauney, G. Kotsakis and L. Macpherson, 31 October 2023, Journal of Dental Research.DOI: 10.1177/ 00220345231200814.